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Abstract Rana catesbeiana ribonuclease (RC-RNase) and
onconase were proven to own anti-tumor activity. While
molecular determinants of onconase-induced cell death have
become more explicit, the RC-RNase-induced death pathway
remains presently unknown. Here we demonstrated that RC-
RNase-induced molecular cascades in caspase-3-deficient MCF-
7 cells did not include activation of initiation caspase-8 and -9.
Cleavage timing suggested that procaspase-2 and -6 might be
processed by active caspase-7 in MCF-7 cells. Caspase-7 was
also responsible for cleavage of the poly(ADP-ribose) polymer-
ase. Furthermore, we reported that overexpression of Bcl-XL
could raise the survival rates of MCF-7 cells treated with RC-
RNase and onconase. ß 2001 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
Key words: Onconase; Caspase; Bcl-XL ; MCF-7;
Rana catesbeiana ribonuclease
1. Introduction
Several frog oocyte-derived tumoricidal ribonucleases are
noted these days, such as RC-RNase from Rana catesbeiana
and onconase from Rana pipiens [1,2]. It is noted that onco-
nase has been at the phase III clinical trials in the USA as an
anti-tumor drug [2,3]. The pyrimidine-guanine sequence spe-
ci¢c RC-RNase shares 48.2% amino acid sequence homology
to onconase. Both contain an identical lectin domain that is
thought to be related with cytotoxicity [4]. We previously
demonstrated that cytotoxicity of RC-RNase is much more
likely to be di¡erentiation-related, but not proliferation-re-
lated [5]. Despite their potential in cancer therapy, the inter-
nalization of these cytotoxic ribonucleases into cells and the
mechanisms triggering death remain currently unclear.
Iordanov et al. Lipofectin-mediatedly delivered onconase
into HeLa cells and reported that procaspase-9, -3, and -7
were processed in these cells and caspase-9 activation is
Bax- and cytochrome c-independent [6]. Since there were no
apparent apoptotic or necrotic characteristics observed in the
hepatoma cells treated with RC-RNase [5], we undertook to
further de¢ne this type of cell death. We utilized caspase-3-
de¢cient MCF-7 breast cancer cells to investigate if caspase
activation was involved in RC-RNase-induced cell death and
how caspase cascades were led to precipitate the dead-end
circumstances.
The distinct caspase machinery would be initiated in the
process of receptor-mediated apoptosis or mitochondria-medi-
ated apoptosis [7^9]. Binding of ligands onto the cell surface
death receptors activates caspase-8 which can in succession
activate the executioner caspase-3. Caspase-9 is the apical
caspase participating in mitochondria-mediated apoptosis
and can directly process procaspase-3 and its close relative
procaspase-7. Activation of caspase-8/-3 or caspase-9/-3 and
-7 ensures that apoptosis is unavoidable. Poly(ADP-ribose)
polymerase (PARP) is one of the principle substrates cleaved
by caspases, primarily by caspase-3 and -7; therefore, the
cleavage of PARP can further de¢ne that the death was
from caspase activation [7].
Mitochondrial disruptions were reported in hepatoma cells
treated with RC-RNase in combination with IFN-Q [5] and
seen in HeLa cells treated with RC-RNase alone (unpublished
data). It is also known that Bcl-XL can e¡ectively reverse
mitochondria-mediated cell death [10]. To examine if Bcl-XL
could act against cytotoxicity derived from RC-RNase, MCF-
7 cells were permanently transfected with bcl-xL. Herein, we
present a di¡erent caspase activation pathway in MCF-7 cells
treated with RC-RNase and report for the ¢rst time that over-
expression of Bcl-XL could signi¢cantly rescue MCF-7 cells
from death caused by both RC-RNase and onconase.
2. Materials and methods
2.1. Chemicals, cell lines, and culture conditions
Onconase puri¢ed from oocytes of R. pipiens was a gift from the
Alfacell Corp. (USA). PARP, caspase-2 and caspase-8 monoclonal
antibodies were purchased from Pharmingen. Caspase-6 and actin
monoclonal antibodies were purchased from Chemicon. Caspase-7
and -9 monoclonal antibodies were purchased respectively from On-
cogene and Upstate. Bcl-XS=L polyclonal antiserum was purchased
from Santa Cruz. The human breast carcinoma cell line MCF-7 was
cultured in Dulbecco’s modi¢ed Eagle’s medium supplemented with
10% fetal bovine serum, 2 mM L-glutamine, 100 IU/ml penicillin/
streptomycin, 1 mM sodium pyruvate, and 0.1 mM non-essential ami-
no acids.
2.2. Oocyte preparation from R. catesbeiana and puri¢cation of
RC-RNase
Mature female R. catesbeiana were anesthetized on ice and ovaries
were removed. Oocytes were released from ovaries by cutting them
into small pieces, washing in 0.09 M NaCl, and ultracentrifugation at
150 000Ug in a Beckman SW41 rotor. Yolk granule pellet was ho-
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mogenized in 0.09 M NaCl and stirred at 4‡C for 20 min. The soluble
fraction was obtained by centrifugation (15 000Ug) followed by £ow-
ing through cheesecloth and made to contain HEPES (20 mM, pH
7.9) and EDTA (0.1 mM). Precipitates were removed by centrifuga-
tion (16 500Ug, 25 min) on each of the 4 days. The supernatant was
then dialyzed for 3 days in PC bu¡er (20 mM HEPES, pH 7.9, 0.1
mM EDTA) containing 0.07 M KCl and the precipitated dross was
removed by centrifugation at 16 500Ug each day. The dialyzed super-
natant was loaded onto a phosphocellulose column (P11, Whatman).
Active fractions were collected and loaded onto a carboxymethyl cel-
lulose column (CM52, Whatman) [11]. Fractions with ribonuclease
activity were collected, analyzed on a 13.3% SDS^polyacrylamide
gel, and visualized by silver staining. Pure RC-RNase was concen-
trated by another phosphocellulose column eluted with 3 M KCl.
RC-RNase for cytotoxicity studies was dialyzed in 200 mM phosphate
bu¡er (pH 7.0).
2.3. Ribonuclease activity assay
Puri¢ed RC-RNase was serially diluted, incubated with SDS-load-
ing bu¡er (0.125 M Tris^HCl, pH 8.0, 2% SDS, and 5% glycerol) for
15 min at 50‡C, and then analyzed on a 13.3% RNA-cast SDS^poly-
acrylamide gel. In situ RNA digestion in the gel was visualized by
methods described previously [12].
2.4. Dinucleotide CpG cleavage assay
Two micrograms of dinucleotide CpG was incubated with serial
dilutions of RC-RNase in 50 mM Tris^HCl, pH 8.0 for 15 min at
37‡C. Reaction mixtures were spotted on a PEI-cellulose F thin layer
plate (Merck), developed in 1.6 M LiCl:0.5 M acetic acid, and visu-
alized using a UV illuminator at 254 nm [13].
2.5. Cell viability assay
Cells were grown in 96-well cell culture plates overnight and then
treated with culture medium containing RC-RNase (20 Wg/ml) or
onconase (20 Wg/ml). Every 24th hour, XTT assays (Roche) were
performed according to the manufacturer’s instructions and measured
at 492 nm.
2.6. Establishment of transfectants constitutively expressing Bcl-XL
Human bcl-xL/PCR 3.1 plasmid was constructed previously [14].
MCF-7 cells stably expressing Bcl-XL were cloned from a single cell
by the limiting dilution method [15]. Brie£y, cells were transfected
using lipofectamine (Gibco) and selected by 200 Wg/ml geneticin (Gib-
co). Transfectants were distributed into 96-well microtiter plates to
make each well contain one cell. Once cell colonies derived from
each single cell became con£uent, they were transferred to tissue cul-
ture £asks and maintained in complete medium containing 200 Wg/ml
geneticin. Expression of Bcl-XL in these cell clones was veri¢ed by
Western blotting.
2.7. Western blotting
Cells were lysed in RIPA bu¡er containing protease inhibitor cock-
tail (Calbiochem). Proteins in cell lysates were size separated in a
13.3% SDS^polyacrylamide gel and transferred to the nitrocellulose
membrane. The membrane was blocked with 5% non-fat milk and 1%
NP-40 in TBS-T (0.8% NaCl; 0.02% KCl; 25 mM Tris^HCl; 0.05%
Tween 20, pH 7.4) for 2 h and then reacted at 4‡C with primary
antibodies (1:500) overnight. The membrane was then incubated
with biotinylated anti-mouse IgG or anti-rabbit IgG antibodies
(1:2000). After further incubation with streptavidin^horseradish per-
oxidase conjugates (1:4000), labeled proteins were visualized by the
Super Signal1 Chemiluminescent-HRP substrate system (Pierce,
Rockford, IL, USA).
3. Results
3.1. Successful puri¢cation of RC-RNase
Our modi¢ed puri¢cation method with prolonged precipi-
tation time and increased centrifugation force e⁄ciently re-
duced the dross compared with the previous method. Active
eluates from the phosphocellulose column contained RC-
RNase and another protein shown beneath the band of RC-
RNase (Fig. 1A, lane 3). Pure RC-RNase was gained after
elution from the carboxymethyl cellulose column (Fig. 1A,
lane 4). RC-RNase possessing ribonuclease activity was dem-
onstrated by in situ RNA digestion in an RNA-cast SDS^
polyacrylamide gel (Fig. 1B). We also characterized RC-
RNase by o¡ering the speci¢c dinucleotide CpG for its diges-
tion into 2P,3P-cyclic CMP (Cp) and guanosine (G) (Fig. 1C).
3.2. Overexpression of Bcl-XL rescued death induced by
ribonucleases in MCF-7 cells
After transfection with bcl-xL/PCR 3.1 plasmid and selec-
tion in medium containing geneticin, the MCF-7 permanent
transfectants were detected to constitutively express Bcl-XL
(Fig. 2). The bcl-xL/PCR 3.1 transfectants were less suscepti-
ble to RC-RNase and onconase treatment (Fig. 3A,B). Over-
expression of Bcl-XL could act more e⁄ciently against the
Fig. 1. A: Tracing of RC-RNase during cation exchange column puri¢cation by silver staining. Lanes: 1, protein markers; 2, supernatant after
precipitation; 3, active eluates of the phosphocellulose column; 4, active eluates of the carboxymethyl cellulose column; 5, concentrated eluates
of another phosphocellulose column. B: Identi¢cation of RC-RNase by in situ RNA digestion in a 13.3% RNA-containing SDS^polyacryl-
amide gel. Amount of loaded RC-RNase from lane 1 to lane 5 was as follows: 0.2, 0.1, 0.05, 0.025, and 0.0125 Wg. C: Characterization of
RC-RNase by its dinucleotide CpG cleavage activity. Amount of utilized RC-RNase from lane 1 to lane 9 was as follows: 1031U(1/2)0,
1031U(1/2)1, T, 1031U(1/2)8 Wg. Dinucleotide cleavage activity in the presence of 2 Wg CpG is visualized in lane 5 (1031U(1/2)4 Wg RC-
RNase).
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cytotoxicity induced by RC-RNase than that by onconase.
Observations on MCF-7 cells also showed that 20 Wg/ml
RC-RNase was more cytotoxic than 20 Wg/ml onconase.
3.3. Caspase activation induced by RC-RNase in
caspase-3-de¢cient MCF-7 cells was di¡erent from
the two major caspase pathways of apoptosis
Procaspase-8 and -9 were not cleaved in the caspase-3-de¢-
cient MCF-7 cells even after RC-RNase treatment for 96 h
(Fig. 4, lane 3). Procaspase-7 was processed to the active
caspase-7 within 48 h (Fig. 4, lane 2). Cleavage of procas-
pase-7 was found to be prior to that of procaspase-2 and -6
(Fig. 4, lanes 2 and 3) because procaspase-2 and -6 were not
cleaved after treatment with RC-RNase for 48 h. The process-
ing patterns of procaspases in MCF-7 cells overexpressing
Bcl-XL were almost analogous to those in MCF-7 cells (Fig.
4, lanes 4^6). Judging from the fact that PARP was cleaved
within 48 h, it is most likely that the activated caspase-7 was
responsible for PARP cleavage in the caspase-3-de¢cient
MCF-7 cells treated with RC-RNase. Cleavage of PARP
into the major 89-kDa fragment became evident while
MCF-7 cells were incubated longer with RC-RNase (Fig. 5,
lanes 3 and 4).
4. Discussion
There was accumulating evidence that onconase-treated
cells display the characteristics of apoptosis [6]. Although sev-
eral pivotal hallmarks of apoptosis (e.g. oligonucleosomal
degradation of nuclear DNA and exposure of phosphatidyl-
serine) and necrosis (e.g. penetration by dyes) were not exam-
ined in RC-RNase-induced cell death, mitochondrial disrup-
tions were reported to be responsible for this mode of cell
death [5]. Circumvention of RC-RNase-induced cell death
by overexpression of Bcl-XL in MCF-7 cells o¡ered further
evidence that the death is strongly related with mitochondria.
The di¡erent capacity of Bcl-XL on reversing RC-RNase-
and onconase-triggered cell death indicated the employment
of distinct death pathways by each of the two cytotoxic ribo-
nucleases. Since the targeted cellular substrates for RC-RNase
and onconase were rRNA and tRNA, respectively [6,11,16], it
is quite reasonable that the two ribonucleases did not initiate
the same death pathway. As shown in Fig. 3A, overexpression
of Bcl-XL could partially elevate the survival percentage of
RC-RNase-treated cells. Together with the fact that Bcl-XL
did not rescue RC-RNase-induced cell death by inhibiting
activation of caspases (Fig. 4, lanes 4^6), we suggested that
Fig. 2. Western blot analysis of Bcl-XL expression. Lane 1, endoge-
nous Bcl-XL expressed in MCF-7 cells; lane 2, Bcl-XL overexpres-
sion in MCF-7 cells transfected with bcl-xL/PCR 3.1 plasmids. De-
tection of actin served as protein loading control.
Fig. 3. Survival rates after treatment. The 5-day survival rates of
the two indicated cell types were obtained after treatment with RC-
RNase (20 Wg/ml) (A) and onconase (20 Wg/ml) (B). Each data point
was calculated from three quadruple groups and represented as
mean þ S.D. RC-RNase was more cytotoxic than onconase to
MCF-7 cells.
Fig. 4. Caspase activation in response to RC-RNase (20 Wg/ml).
MCF-7 cells were treated for 0 h (lane 1), 48 h (lane 2), and 96 h
(lane 3); MCF-7 transfectants overexpressing Bcl-XL were treated
for 0 h (lane 4), 48 h (lane 5), and 96 h (lane 6). Protein loading
controls were done by detecting actin simultaneously.
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the elevated survival rate was the result of upregulating other
survival signals by Bcl-XL.
Caspase activation ensured the irreversibility of cell death.
Cleavage of critical cellular substrates by caspases could ¢-
nally result in morphological alterations of the cells. Unpro-
cessing of procaspase-8 pointed out that RC-RNase-induced
cell death was not initiated from the cell surface death recep-
tors. To our surprise, the apical initiator caspase-9 participat-
ing in mitochondria-mediated cell death was also not acti-
vated in the cell death triggered by RC-RNase. Caspase-9
activation in onconase-treated cells was considered to be atyp-
ical because it was Bax- and cytochrome c-independent [6].
Our observation on severe mitochondrial disruptions caused
by RC-RNase might explain the lack of cytochrome c release;
therefore, caspase-9 could not be activated without the par-
ticipation of this critical coactivator. To account for atypical
caspase-9 activation in HeLa cells stimulated by onconase, we
should take the Lipofectin-mediated delivery into considera-
tion. As indicated, simply adding onconase without Lipofectin
to the medium was not cytotoxic at concentrations of up to 30
Wg/ml [6].
Activation of the executioner caspase-7 in caspase-3 null
MCF-7 cells treated with RC-RNase suggested that caspase-
7 might functionally compensate for the lack of caspase-3.
Procaspase-2 and -6 were known to be cleaved chie£y by
caspase-3 [7]. That cleavage of procaspase-2 and -6 fell behind
activation of the executioner caspase-7 o¡ered evidence that
caspase-7 might play a role in processing procaspase-2 and -6
under the circumstances where caspase-3 was defected (Fig. 4,
lanes 2, 3, 5 and 6). Because cleavage of PARP was earlier
observed (Fig. 5) within 48 h, we thought that PARP was
cleaved by caspase-7 in MCF-7 cells. Caspase-2 or -6 could
not process PARP due to cleavage speci¢city [7]. It is, how-
ever, worth investigating what factors stand upstream from
caspase-7 activation.
In view of the distinct caspase activation in MCF-7 cells
stimulated with RC-RNase, we propose that another death
pathway exists that could account for the above-mentioned
atypical apoptotic characteristics.
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Fig. 5. PARP cleavage after treatment. MCF-7 cells treated with
RC-RNase (20 Wg/ml) respectively for 0 h (lane 1), 24 h (lane 2), 48
h (lane 3), and 72 h (lane 4) were subjected to Western blotting us-
ing an antibody against full-length PARP and its cleaved 89-kDa
fragment. Detection of actin served as internal control.
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